Ow, Thomas J.
Mehta, Vikas
Kim, Seokhwa
Vakil, Mayand
Friedmann, Patricia
In, Haejin
Article History
First Online: 9 January 2022
Disclosures
: Dr. T.J. Ow is the site Principal Investigator for a phase 0 study supported by Presage Biosciences, Inc., with substudies sponsored by Takeda (Millennium Pharmaceuticals, Inc.) and Bristol Myers Squibb. The phase 0 study is not focused on medullary thyroid carcinoma or radiation treatment.